{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:39:22Z","timestamp":1794296362687,"version":"4.9.0"},"reference-count":54,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241223, U20A20360"],"award-info":[{"award-number":["82241223, U20A20360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["No. YDZJ202201ZYTS014"],"award-info":[{"award-number":["No. YDZJ202201ZYTS014"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","award":["Grant NO. JLSWSRCZX2020-045"],"award-info":[{"award-number":["Grant NO. JLSWSRCZX2020-045"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,10,29]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Different serum lipids and lipid-modifying targets should affect the risk of cholelithiasis differently, however, whether such effects are causal is still controversial and we aimed to answer this question.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      We prospectively estimated the associations of four serum lipids with cholelithiasis in UK Biobank using the Cox proportional hazard model, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG). Furthermore, we estimated the causal associations of the genetically predicted serum lipids with cholelithiasis in Europeans using the Mendelian randomisation (MR) design. Finally, both drug-target MR and colocalisation analyses were performed to estimate the lipid-modifying targets\u2019 effects on cholelithiasis, including\n                      <jats:italic>HMGCR<\/jats:italic>\n                      ,\n                      <jats:italic>NPC1L1<\/jats:italic>\n                      ,\n                      <jats:italic>PCSK9<\/jats:italic>\n                      ,\n                      <jats:italic>APOB, LDLR, ACLY, ANGPTL3, MTTP, PPARA, PPARD<\/jats:italic>\n                      and\n                      <jats:italic>PPARG<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that serum levels of LDL-C and HDL-C were inversely associated with cholelithiasis risk and such associations were linear. However, the serum level of TC was non-linearly associated with cholelithiasis risk where lower TC was associated with higher risk of cholelithiasis, and the serum TG should be in an inverted \u2018U-shaped\u2019 relationship with it. The MR analyses supported that lower TC and higher TG levels were two independent causal risk factors. The drug-target MR analysis suggested that\n                      <jats:italic>HMGCR<\/jats:italic>\n                      inhibition should reduce the risk of cholelithiasis, which was corroborated by colocalisation analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Lower serum TC can causally increase the risk of cholelithiasis. The cholelithiasis risk would increase with the elevation of serum TG but would decrease when exceeding 2.57\u2009mmol\/L. The use of\n                      <jats:italic>HMGCR<\/jats:italic>\n                      inhibitors should prevent its risk.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-330784","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T13:20:22Z","timestamp":1699536022000},"page":"521-532","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis"],"prefix":"10.1136","volume":"73","author":[{"given":"Lanlan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4656-4955","authenticated-orcid":false,"given":"Guoyue","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"2025121301064738000_73.3.521.1","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025121301064738000_73.3.521.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61903-0"},{"key":"2025121301064738000_73.3.521.3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.32183","article-title":"Insights into modifiable risk factors of cholelithiasis: a Mendelian randomization study","volume":"75","author":"Chen","year":"2022","journal-title":"Hepatology"},{"key":"2025121301064738000_73.3.521.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-022-01635-9","article-title":"Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis","volume":"21","author":"Zhang","year":"2022","journal-title":"Lipids Health Dis"},{"key":"2025121301064738000_73.3.521.5","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2203514","article-title":"Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone","volume":"55","author":"Wan","year":"2023","journal-title":"Ann Med"},{"key":"2025121301064738000_73.3.521.6","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq361"},{"key":"2025121301064738000_73.3.521.7","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040536","article-title":"Association between gallstone disease and statin use: a nested case-control study in Korea","volume":"16","author":"Kwon","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025121301064738000_73.3.521.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604304"},{"key":"2025121301064738000_73.3.521.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1601"},{"key":"2025121301064738000_73.3.521.10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s11695-022-05947-8","article-title":"Risk factors for symptomatic gallstone disease and gallstone formation after Bariatric surgery","volume":"32","author":"Haal","year":"2022","journal-title":"Obes Surg"},{"key":"2025121301064738000_73.3.521.11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.1.109"},{"key":"2025121301064738000_73.3.521.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.011"},{"key":"2025121301064738000_73.3.521.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv108"},{"key":"2025121301064738000_73.3.521.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.08.013"},{"key":"2025121301064738000_73.3.521.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z"},{"key":"2025121301064738000_73.3.521.16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"key":"2025121301064738000_73.3.521.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101471","article-title":"ukbpheno V1.0: An R package for phenotyping health-related outcomes in the UK Biobank","volume":"3","author":"Yeung","year":"2022","journal-title":"STAR Protoc"},{"key":"2025121301064738000_73.3.521.18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq340"},{"key":"2025121301064738000_73.3.521.19","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"2025121301064738000_73.3.521.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219"},{"key":"2025121301064738000_73.3.521.21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038984","article-title":"Multivariable Mendelian randomization and mediation","volume":"11","author":"Sanderson","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025121301064738000_73.3.521.22","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx207"},{"key":"2025121301064738000_73.3.521.23","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"2025121301064738000_73.3.521.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312086"},{"key":"2025121301064738000_73.3.521.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"2025121301064738000_73.3.521.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02867-x","article-title":"Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study","volume":"21","author":"Cronj\u00e9","year":"2023","journal-title":"BMC Med"},{"key":"2025121301064738000_73.3.521.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008720","article-title":"Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses","volume":"16","author":"Wallace","year":"2020","journal-title":"PLoS Genet"},{"key":"2025121301064738000_73.3.521.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-018-0164-2","article-title":"Publisher correction: detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"2025121301064738000_73.3.521.29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41588-020-0631-4","article-title":"Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics","volume":"52","author":"Morrison","year":"2020","journal-title":"Nat Genet"},{"key":"2025121301064738000_73.3.521.30","article-title":"Polynomial Mendelian randomization reveals non-linear causal effects for obesity-related traits","volume":"3","author":"Sulc","year":"2022","journal-title":"HGG Adv"},{"key":"2025121301064738000_73.3.521.31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10654-017-0276-5","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2025121301064738000_73.3.521.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260401"},{"key":"2025121301064738000_73.3.521.33","article-title":"Exploration of the causal association between behavioral risk factors and gallstone disease development in two European ancestry populations","volume":"15","author":"Alyahyawi","year":"2023","journal-title":"Cureus"},{"key":"2025121301064738000_73.3.521.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.042"},{"key":"2025121301064738000_73.3.521.35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/hepr.12433","article-title":"Statin use and risk of gallstone disease: a meta-analysis","volume":"45","author":"Kan","year":"2015","journal-title":"Hepatol Res"},{"key":"2025121301064738000_73.3.521.36","doi-asserted-by":"crossref","first-page":"174376","DOI":"10.1016\/j.ejphar.2021.174376","article-title":"Recent advances, novel targets and treatments for cholelithiasis; a narrative review","volume":"908","author":"E","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"2025121301064738000_73.3.521.37","first-page":"7475626","article-title":"Peroxisome proliferator-activated receptor-\u0393 prevents cholesterol gallstone formation in C57Bl mice by regulating bile acid synthesis and enterohepatic circulation","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025121301064738000_73.3.521.38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep4.1858","article-title":"Pcsk9 deletion promotes murine nonalcoholic steatohepatitis and hepatic carcinogenesis: role of cholesterol","volume":"6","author":"Ioannou","year":"2022","journal-title":"Hepatol Commun"},{"key":"2025121301064738000_73.3.521.39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21616"},{"key":"2025121301064738000_73.3.521.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.08.029"},{"key":"2025121301064738000_73.3.521.41","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M046342"},{"key":"2025121301064738000_73.3.521.42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30060"},{"key":"2025121301064738000_73.3.521.43","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000034044.95911.DC"},{"key":"2025121301064738000_73.3.521.44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003898","article-title":"The evolution of Mendelian randomization for investigating drug effects","volume":"19","author":"Gill","year":"2022","journal-title":"PLoS Med"},{"key":"2025121301064738000_73.3.521.45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.865444"},{"key":"2025121301064738000_73.3.521.46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003897","article-title":"Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: a Mendelian randomization analysis","volume":"19","author":"Yarmolinsky","year":"2022","journal-title":"PLoS Med"},{"key":"2025121301064738000_73.3.521.47","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000161"},{"key":"2025121301064738000_73.3.521.48","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25642"},{"key":"2025121301064738000_73.3.521.49","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100020","article-title":"Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases","volume":"1","author":"Wen","year":"2023","journal-title":"eGastroenterology"},{"key":"2025121301064738000_73.3.521.50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","article-title":"PCSK9 genetic variants and risk of type 2 diabetes: a Mendelian randomisation study","volume":"5","author":"Schmidt","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121301064738000_73.3.521.51","doi-asserted-by":"publisher","DOI":"10.2337\/dci17-0069"},{"key":"2025121301064738000_73.3.521.52","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(19)30158-5","article-title":"Effects of Alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"7","author":"Ray","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121301064738000_73.3.521.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"},{"key":"2025121301064738000_73.3.521.54","article-title":"Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack","volume":"1","author":"Liu","year":"2023","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-330784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:06:55Z","timestamp":1765616815000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-330784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2,23]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/gutjnl-2023-330784"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-330784","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]}}}